ATLANTA -- MedAssets Supply Chain Systems and Inviro Medical Devices have entered into an agreement that provides MedAssets customers access to Inviros extensive portfolio of safety hypodermic needle and syringe products.
MedAssets Supply Chain Systems selected Inviro Medical through an assessment conducted at its Technology and Innovation Forum in September 2006. This annual event is a forum that showcases companies of all sizes with new and unique technology. These companies are reviewed and ranked by the MedAssets Supply Chain Systems customer advisory committees. Based on the committee ranking MedAssets writes GPO agreements with select manufacturers. John Kautzer, director of distribution, stated, The recently completed agreement with Inviro Medical brings a unique safety technology to our mutual customers. It also helps broaden the overall safety portfolio that MedAssets offers. This new agreement starts March 1, 2007.
We are pleased to enter into this supplier partnership with the MedAssets team, says Jim Charlesworth, senior vice president of sales for Inviro Medical Devices. The clinical response to our line of safety products during the MedAssets Supply Chain Systems Technology and Innovation Forum was extremely positive, and mirrors what weve seen across the country. There is a definitive need for Inviros unique, patented safety syringe technology.
Inviro Medical Devices engineers and markets safe medication delivery systems, including the patented InviroSNAP!® Safety Syringe. After years of research to develop its patents and refine its product designs, the company is addressing the growing $1.6 billion safety syringe market and introducing its breakthrough infection control technology in North America. The companys flagship product, the innovative SNAP! Safety Syringe is a manually retractable safety syringe that provides distinct protection and performance advantages. While most safety syringes are retro-fitted using add-on pieces, this device is uniquely engineered with the safety feature integral to the design.
It looks and functions like a traditional syringe and is easy to use.
We are delighted to enter this agreement with MedAssets Supply Chain Systems, says Gareth Clarke, chief executive officer of Inviro Medical Devices. Their decision to make Inviros unique safety technology available to their customers represents a significant endorsement of the company and its range of products. We look forward to working with MedAssets to help enhance both employee and patient safety at their customers facilities.
Â
Â
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.
Advancing Infection Prevention With Diagnostic Innovation: Insights From Alesia McKeown, PhD
September 17th 2024Alesia McKeown, PhD, discusses the pivotal role of cutting-edge diagnostic technologies in enhancing infection prevention, especially in high-risk health care environments, during an interview with Infection Control Today.
The Role of Accurate Testing in Preventing Respiratory Illnesses: Insights from Dr. Aparna Ahuja
September 17th 2024On Get Ready for Flu Day, Dr. Aparna Ahuja discusses the importance of accurate respiratory illness testing, the risks of self-diagnosis, and the role of infection prevention personnel in public health education.
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance
September 13th 2024Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.